Malignant neoplasm of brain, including Hilmo

C3_BRAIN_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C71 Hospital discharge: ICD-9 — 191 Hospital discharge: ICD-8 — 191 Cause of death: ICD-10 — C71 Cause of death: ICD-9 — 191 Cause of death: ICD-8 — 191 Cancer registry: Topography ICD-O-3 — C71 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2296
4. Check minimum number of events None	2296
5. Include endpoints None	2296
6. Filter based on genotype QC (FinnGen only)	2048

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BRAIN_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C71
HD_ICD_9	191
HD_ICD_8	191
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C71
COD_ICD_9	191
COD_ICD_8	191
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C71
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of brain, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2048	929	1119
Unadjusted period prevalence (%)	0.43	0.33	0.51
Median age at first event (years)	59.87	56.89	62.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2132: Matched controls
21320

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZXC40

NOMESCO Finland

Use of ultrasound

78.4

323.0

173

AA1AD

NOMESCO Finland

CT of head and brain

5.3

320.0

1178

4055

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3323.7

317.6

299

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

308.0

288

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

474.5

307.7

325

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

307.7

419

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

33.8

307.7

1193

772

N03AX14

ATC

levetiracetam; systemic

64.4

307.7

842

214

N03AF02

ATC

oxcarbazepine; oral

15.4

307.7

395

311

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

30.6

307.7

405

162

WF003

NOMESCO Finland

Adjuvant radiotherapy

4590.6

307.7

390

A04AA02

ATC

granisetron; systemic, transdermal

1064.7

307.7

611

N03AX18

ATC

lacosamide; systemic

65.5

307.7

244

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

57.0

307.7

291

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1092

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

30.3

307.7

542

237

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

34.9

307.7

409

144

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

57.5

307.7

640

158

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

189.4

307.7

174

H02AB02

ATC

dexamethasone; systemic

404.4

307.7

1435

108

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

433.3

307.7

333

Z51.5

ICD-10 Finland

Palliative care

25.2

307.7

629

348

L01AX03

ATC

temozolomide; systemic

+∞

307.7

839

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

744.1

307.7

1035

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

307.7

413

WF002

NOMESCO Finland

Radical radiotherapy

572.8

307.7

583

XX3DW

NOMESCO Finland

Time consuming IT work

17.6

307.7

550

413

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

629.5

307.7

558

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

29.6

307.7

907

521

A04AA01

ATC

ondansetron; systemic, rectal

25.2

307.7

503

258

A03FA01

ATC

metoclopramide; systemic, rectal

13.2

307.7

1020

1384

ZXC95

NOMESCO Finland

Use of surgical navigator

66.2

307.7

417

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

1094.0

298.2

285

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

118.7

283.0

144

R56.8

ICD-10 Finland

Other and unspecified convulsions

8.8

278.8

387

523

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

275.1

258

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

274.0

257

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

17.3

271.5

231

149

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

270.7

254

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

967.2

266.6

256

AA1BD

NOMESCO Finland

Extensive CT of head and brain

19.5

262.9

210

119

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

255.5

240

G40.9

ICD-10 Finland

Epilepsy, unspecified

10.1

247.0

299

338

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

242.4

228

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

238.1

224

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

29.2

230.3

155

XA800

NOMESCO Finland

Neuropsychological investigation

8.4

230.1

327

451

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

215.3

203

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.6

212.3

664

1915

G40.10

ICD-10 Finland

Simple partial seizures

39.5

211.8

130

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.5

208.8

481

1078

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

557.8

207.6

203

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

25.2

205.8

146

WX882

NOMESCO Finland

High dependency care

10.5

201.5

233

246

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

415.8

193.2

191

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

408.6

190.0

188

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

185.2

175

JN4BD

NOMESCO Finland

Extensive body CT

7.9

182.6

269

384

N03AB02

ATC

phenytoin; systemic

17.7

180.9

150

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

178.7

169

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

25.0

173.4

123

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

+∞

173.3

164

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

171.2

162

N02AA05

ATC

oxycodone; systemic

4.2

168.9

555

1634

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

11.2

162.4

177

171

ZX050

NOMESCO Finland

Stereotactic radiotherapy

294.7

162.0

163

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

562.1

160.1

157

WF004

NOMESCO Finland

Palliative radiotherapy

1635.0

155.1

149

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

+∞

151.9

144

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

32.1

150.7

N05BA09

ATC

clobazam; oral

26.1

146.3

102

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

16.9

145.7

123

JN4AD

NOMESCO Finland

Body CT examination

5.8

145.5

289

558

WZC00

NOMESCO Finland

Treatment plan or consultation

3.2

145.4

926

4129

ZXE20

NOMESCO Finland

More than three and less than five hours

4.2

145.1

460

1307

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

142.3

135

N05CD08

ATC

midazolam; nasal, systemic

9.4

141.0

174

199

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

17.5

136.4

113

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

132.7

126

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

131.6

125

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.7

128.9

258

500

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1314.9

128.5

124

WF049

NOMESCO Finland

Radiotherapy of metastasis

661.6

127.8

125

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

269.9

125.5

127

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

+∞

123.1

117

ZX090

NOMESCO Finland

Other technic of radiotherapy

221.1

122.1

125

N74

ICPC

Malignant neoplasm nervous system

622.2

120.4

118

H02AB09

ATC

hydrocortisone; systemic

9.5

119.3

145

162

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

+∞

118.9

113

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

+∞

116.7

111

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

115.7

110

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

23.0

115.0

WX402

NOMESCO Finland

General anaesthesia

3.2

113.3

602

2362

WZC30

NOMESCO Finland

Teaching

3.6

109.1

438

1445

ZX070

NOMESCO Finland

Intensity modified radiotherapy

375.9

108.3

108

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

+∞

107.2

102

G91.1

ICD-10 Finland

Obstructive hydrocephalus

26.4

106.8

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

10.4

106.6

121

123

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

193.2

106.4

110

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

167.2

106.3

111

L03AA02

ATC

filgrastim; parenteral

167.2

106.3

111

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

+∞

106.1

101

H53.4

ICD-10 Finland

Visual field defects

8.7

105.6

138

169

AAA10

NOMESCO Finland

Biopsy through craniotomy

538.6

104.6

103

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

104.0

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

+∞

101.9

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

101.9

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

12.7

101.6

100

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

264.9

99.6

101

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

96.7

643

2824

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

94.5

N03AF01

ATC

carbamazepine; oral, rectal

4.9

93.3

223

501

183

Kela drug reimbursment

Lamotrigin and topiramate

14.3

91.6

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

+∞

91.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.8

90.5

173

319

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

45.3

89.4

C61

ICD-10 Finland

Malignant neoplasm of prostate

311.7

88.4

WW500

NOMESCO Finland

Blood transfusion

8.5

88.1

116

143

A79

ICPC

Malignancy NOS

450.7

87.8

A02BC02

ATC

pantoprazole; systemic

2.7

86.2

1569

10910

115

Kela drug reimbursment

Breast cancer

+∞

85.0

8000/3-C71.9

ICD-O-3

Neoplasm, malignant of brain, NOS

+∞

85.0

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

83.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.9

83.7

493

2012

N03AG01

ATC

valproic acid; systemic, rectal

4.1

83.6

251

672

L03AA13

ATC

pegfilgrastim; parenteral

423.5

82.6

R4150

NOMESCO Finland

Neuropsychological rehabilitation

15.1

82.1

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

17.7

81.9

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

+∞

81.8

ZXM40

NOMESCO Finland

Use of fluorescent substance

202.3

75.7

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

9.4

75.0

101

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

74.4

D70.82

ICD-10 Finland

Drug-induced neutropenia

26.1

73.4

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

22.6

72.2

WX872

NOMESCO Finland

Intensive care

4.2

71.7

203

519

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

71.2

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

71.2

N03AX23

ATC

brivaracetam; systemic

37.4

70.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.1

70.3

108

159

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

25.1

69.4

N76

ICPC

Neoplasm nervous system unspecified

148.9

68.4

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

68.1

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

68.1

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

68.1

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

67.0

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

+∞

67.0

R4110

NOMESCO Finland

Physiotherapy

2.4

66.8

663

3433

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

66.0

XX2RW, ,

NOMESCO Finland

15.4

65.0

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

63.9

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

+∞

63.9

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

62.8

TAB00

NOMESCO Finland

Lumbar puncture

4.3

62.8

169

415

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

9.0

62.3

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

+∞

61.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

60.2

500

2378

G41.9

ICD-10 Finland

Status epilepticus, unspecified

15.1

59.8

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

+∞

59.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

59.7

G40.89

ICD-10 Finland

Other epilepsy

17.5

58.5

R4120

NOMESCO Finland

Occupational therapy

3.5

58.3

219

679

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

92.8

57.2

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

294.4

56.5

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

19.5

56.3

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

562.4

55.8

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

8.3

55.7

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

11.2

55.6

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

+∞

55.5

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

8.6

55.1

A28

ICPC

Limited function/disability NOS

2.4

53.6

472

2291

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

+∞

53.3

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

16.4

53.1

JN4CD

NOMESCO Finland

Very extensive body CT

8.5

52.4

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

52.3

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

+∞

52.3

A04AA55

ATC

palonosetron, combinations; systemic

+∞

51.2

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

+∞

50.2

N05CF01

ATC

zopiclone; oral

2.0

49.9

739

4388

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

48.9

762

4603

Z51.0

ICD-10 Finland

Radiotherapy session

488.7

48.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

47.6

425

2065

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

47.0

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

47.0

L02AE02

ATC

leuprorelin; implant, parenteral

12.4

46.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

46.0

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

+∞

46.0

B01AB10

ATC

tinzaparin; parenteral

2.9

46.0

229

837

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.2

45.8

131

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

457.2

45.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

44.4

794

4992

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

120.1

43.9

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

+∞

43.9

116

Kela drug reimbursment

Prostate cancer

+∞

43.9

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

42.9

Z2445

NOMESCO Finland

Psychologist

3.8

42.7

137

381

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.2

42.6

A98

ICPC

Health maint/preventive medicine

0.5

42.4

1633

18624

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

55.7

41.6

HAB40

NOMESCO Finland

Wedge excision of mammary gland

14.5

40.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

40.5

485

2634

WW300

NOMESCO Finland

Transfer of autologic stem cells

405.0

40.2

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

405.0

40.2

E23.00

ICD-10 Finland

Panhypopituitarism

14.6

40.0

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

+∞

37.6

L01BC06

ATC

capecitabine; oral

+∞

37.6

WX704

NOMESCO Finland

Intubation

2.8

37.1

200

761

XW000

NOMESCO Finland

Bone marrow biopsy

4.9

35.9

172

R47.0

ICD-10 Finland

Dysphasia and aphasia

6.3

35.8

100

101

Kela drug reimbursment

Anterior pituitary hypofunction

8.5

35.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

35.2

248

1076

B01AB05

ATC

enoxaparin; parenteral

1.9

35.0

577

3478

JN6AD

NOMESCO Finland

CT of torso and neck

10.7

34.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.8

34.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.0

34.6

C71.0

ICD-10 Finland

Malignant neoplasm: Cerebrum, except lobes and ventricles

+∞

34.5

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

34.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

34.5

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

33.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

33.4

C71

ICD-10 Finland

Malignant neoplasm of brain

+∞

33.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.2

33.1

140

464

Z2446

NOMESCO Finland

Social worker

2.8

32.8

173

650

C71.70

ICD-10 Finland

Malignant tumor of the brainstem without histology

+∞

32.4

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

+∞

32.4

C50.99

ICD-10 Finland

Breast, unspecified

+∞

32.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

32.4

G40

ICD-10 Finland

Epilepsy

6.8

31.9

HAC20

NOMESCO Finland

Total mastectomy

89.0

31.8

C71.6

ICD-10 Finland

Malignant neoplasm: Cerebellum

+∞

31.3

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

31.3

R4130

NOMESCO Finland

Speech therapy

4.0

31.1

237

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

317.4

30.9

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

47.0

30.6

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

9.9

30.4

ZX112

NOMESCO Finland

Subcutaneous

8.0

30.3

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

30.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

306.6

29.9

WW200, ,

SPAT

0.4

29.7

221

4427

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.0

29.4

ZX120

NOMESCO Finland

Intravenous

2.6

29.4

175

699

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

29.2

C71.50

ICD-10 Finland

Malignant tumor of cerebral ventricle without histology

+∞

29.2

C71.03

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade IV glioma

+∞

29.2

L02BA01

ATC

tamoxifen; oral

40.7

29.0

XA400

NOMESCO Finland

EEG

9.1

28.6

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

36.6

28.4

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

+∞

28.2

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

+∞

28.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

28.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

28.1

138

498

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

28.0

216

973

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

285.1

27.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

27.6

934

6819

WX892

NOMESCO Finland

Monitored bed care

2.5

27.5

187

796

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

+∞

27.1

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

27.0

1432

11692

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.6

26.9

146

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

274.4

26.8

2151

FHL

Resection, big brain

141.8

26.7

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

26.1

N03AX22

ATC

perampanel; oral

31.4

25.9

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

40.6

25.8

L02BG04

ATC

letrozole; oral

4.9

25.3

117

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

25.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

25.0

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

58.8

25.0

WX730

NOMESCO Finland

Conventional respirator

5.1

24.7

104

XX1AD

NOMESCO Finland

Other CT-examination

91.2

24.7

N88

ICPC

Epilepsy

7.3

24.6

N05BA04

ATC

oxazepam; oral

1.7

24.3

543

3529

G91.0

ICD-10 Finland

Communicating hydrocephalus

8.0

24.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

24.1

349

1990

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

24.0

9440/3-C71.0

ICD-O-3

Glioblastoma, NOS, of cerebrum

+∞

24.0

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

38.0

23.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

242.6

23.7

C71.59

ICD-10 Finland

Malignant tumor of cerebral ventricle other or unspecified histology

+∞

23.0

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

23.0

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

23.0

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

23.0

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

23.0

Z3231

NOMESCO Finland

Registered nurse

1.7

22.8

521

3397

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

22.7

228

4171

D69.5

ICD-10 Finland

Secondary thrombocytopenia

40.6

22.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

232.4

22.7

XCK00

NOMESCO Finland

Perimetry

2.5

22.5

150

631

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.9

22.4

H02AB04

ATC

methylprednisolone; systemic

1.9

22.2

302

1685

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

21.9

C71.7

ICD-10 Finland

Malignant neoplasm: Brain stem

+∞

21.9

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

+∞

21.9

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.1

21.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

21.7

129

514

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.8

21.5

N18

ICPC

Paralysis/weakness

3.6

21.4

197

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

21.4

220

1110

WZC15, ,

NOMESCO Finland

43.8

21.4

ZXA00

NOMESCO Finland

Right side

1.7

21.1

504

3316

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

20.9

9440/3-C71.8

ICD-O-3

Glioblastoma, NOS, of overlapping lesion of brain

+∞

20.9

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

+∞

20.9

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

20.9

R51.80

ICD-10 Finland

Headache

1.8

20.8

334

1963

A04AD12

ATC

aprepitant; systemic

212.0

20.6

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

111.1

20.6

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

22.6

20.4

ZXD05

NOMESCO Finland

Urgent procedure

1.6

20.2

589

4070

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

3.5

20.2

205

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.0

20.2

324

AAF00

NOMESCO Finland

Ventriculostomy

6.4

20.1

GD1AA, ,

SPAT

0.3

20.0

2069

A06AD11

ATC

lactulose; oral

1.9

20.0

302

1740

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

19.9

122

493

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

19.9

234

4097

WPB10

NOMESCO Finland

Making a convalescent care decision

36.1

19.8

G93.6

ICD-10 Finland

Cerebral oedema

+∞

19.8

C71.65

ICD-10 Finland

Malignant tumor of the cerebellum primary neuroectodermal tumor

+∞

19.8

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

+∞

19.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

19.8

C71.02

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles grade III glioma

+∞

19.8

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.3

19.8

121

HA1AA

NOMESCO Finland

X-ray mammography

3.3

19.8

233

N75

ICPC

Benign neoplasm nervous system

106.0

19.6

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

201.8

19.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

201.8

19.6

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

6.0

19.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

18.8

225

1199

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

+∞

18.8

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

18.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

18.8

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

18.8

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

18.8

AA1AA

NOMESCO Finland

Head X-ray examination

6.6

18.8

RS221, ,

NOMESCO Finland

4.5

18.7

101

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.9

18.7

144

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.4

18.7

201

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

191.6

18.6

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

191.6

18.6

R50.9

ICD-10 Finland

Fever, unspecified

1.8

18.5

297

1743

2152

FHL

Extraction, big brain

30.3

18.3

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

30.3

18.3

C10AA07

ATC

rosuvastatin; oral

0.6

18.2

319

5000

R41.0

ICD-10 Finland

Disorientation, unspecified

2.8

18.2

326

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.1

346

2134

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.2

18.0

117

WF099

NOMESCO Finland

Other radiotherapy

33.2

18.0

C10AX09

ATC

ezetimibe; oral

0.4

17.9

105

2365

ZXY02

NOMESCO Finland

Neuropsychologist

7.3

17.8

PA2AD

NOMESCO Finland

CT angiography of brain

5.7

17.7

G41.2

ICD-10 Finland

Complex partial status epilepticus

23.0

17.7

1911X

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]

+∞

17.7

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

17.7

L02BB03

ATC

bicalutamide; oral

+∞

17.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

17.7

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

17.7

9421/1-C71.9

ICD-O-3

Pilocytic astrocytoma of brain, NOS

+∞

17.7

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

17.7

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

17.7

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.2

17.7

L03

ICPC

Low back symptom/complaint

0.5

17.7

250

4161

WW409

NOMESCO Finland

Other aferesis

95.9

17.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

181.5

17.5

2159

FHL

Other measure in this category

181.5

17.5

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

181.5

17.5

YX9AW, ,

NOMESCO Finland

181.5

17.5

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

15.7

17.5

N19

ICPC

Speech disorder

4.0

17.5

124

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

29.0

17.4

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.5

17.2

185

3350

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

14.9

17.1

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

5.3

17.0

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

13.3

16.9

102

Kela drug reimbursment

Diabetes insipidus

25.8

16.9

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

22.0

16.9

C71.74

ICD-10 Finland

Malignant tumor of the brainstem ependyoma

+∞

16.7

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

16.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

16.7

19109

ICD-8 Finland

Malignant neoplasm of brain, Unspecified

+∞

16.7

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

16.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

16.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

16.7

N03AX11

ATC

topiramate; oral

3.3

16.6

191

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.7

16.3

140

OAB43, ,

SPAT

0.6

16.2

255

4135

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

16.2

162

809

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

47.9

16.0

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.6

16.0

391

N28

ICPC

Limited function/disability (N)

3.4

15.9

166

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

15.9

356

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

15.8

572

7632

ZXA05

NOMESCO Finland

Left side

1.6

15.7

435

2945

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.6

15.7

225

3750

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

15.6

C71.51

ICD-10 Finland

Malignant tumor of cerebral ventricle ependymoma

+∞

15.6

L01CB01

ATC

etoposide; systemic

+∞

15.6

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

15.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

15.6

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

15.6

E23.2

ICD-10 Finland

Diabetes insipidus

26.5

15.6

NK6AN

NOMESCO Finland

Total body bone isotope imaging

26.5

15.6

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

85.7

15.6

D33.12

ICD-10 Finland

Cerebellum

161.1

15.5

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

15.4

113

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

38.3

15.4

H47.2

ICD-10 Finland

Optic atrophy

12.4

15.4

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

17.9

15.1

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.5

15.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

15.1

354

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

45.3

15.1

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.4

15.0

H01AC01

ATC

somatropin; parenteral

10.9

15.0

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

14.9

241

1412

CS494

NOMESCO Finland

Other visual field testing

3.0

14.9

231

ZX108

NOMESCO Finland

Inhalation

6.8

14.9

R03AC02

ATC

salbutamol; inhalant

0.7

14.8

685

8747

H53.2

ICD-10 Finland

Diplopia

2.6

14.7

323

C71.61

ICD-10 Finland

Malignant tumor of cerebellum grade II glioma

+∞

14.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

14.6

9450/3-C71.2

ICD-O-3

Oligodendroglioma, NOS, of temporal lobe

+∞

14.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

14.6

D33.03

ICD-10 Finland

Pilosytic lateral astrocytoma of the strobe brain

+∞

14.6

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

+∞

14.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

14.6

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

14.6

N03AF04

ATC

eslicarbazepine; oral

80.7

14.6

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

80.7

14.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

14.5

172

913

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

151.0

14.5

Y77

ICPC

Malignant neoplasm prostate

151.0

14.5

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

36.3

14.4

M01AH05

ATC

etoricoxib; oral

0.7

14.4

814

10043

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

15.5

14.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

14.3

369

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

14.3

211

3500

R4190

NOMESCO Finland

Nutritional therapy

2.7

14.3

281

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.5

14.3

125

2438

M79.6

ICD-10 Finland

Pain in limb

0.7

14.1

495

6692

KAC10

NOMESCO Finland

Total nephrectomy with capsule

42.8

14.1

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.7

14.0

L28

ICPC

Limited function/disability (L)

1.6

14.0

378

2537

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.6

14.0

224

3635

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

10.1

14.0

TPX15

NOMESCO Finland

Removal of vascular injection port

30.2

13.9

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

30.2

13.9

N03AX09

ATC

lamotrigine; oral

2.3

13.7

103

458

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.0

13.6

210

128

Kela drug reimbursment

Cancers of female genital organs

+∞

13.6

C71.92

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade III glioma

+∞

13.6

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

13.6

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

13.6

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

13.6

C72.9

ICD-10 Finland

Malignant neoplasm: Central nervous system, unspecified

+∞

13.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

13.6

9450/3-C71.3

ICD-O-3

Oligodendroglioma, NOS, of parietal lobe

+∞

13.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.0

13.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

13.5

114

533

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

140.9

13.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

13.5

132

654

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

13.4

144

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

13.4

1029

12114

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

10.5

13.2

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

13.2

141

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

13.1

352

2356

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

12.2

13.1

M25.5

ICD-10 Finland

Pain in joint

0.6

13.1

320

4687

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

11.0

13.0

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

22.7

12.9

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

12.8

132

667

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

15.5

12.6

AAA00

NOMESCO Finland

Exploratory craniotomy

70.3

12.6

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

12.5

450

AA5JS

NOMESCO Finland

Extensive PET-MRI of brain metabolism

+∞

12.5

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

12.5

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

12.5

C71.79

ICD-10 Finland

Malignant tumor of the brainstem other or unspecified histology

+∞

12.5

1CD02, ,

NOMESCO Finland

+∞

12.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.5

19107

ICD-8 Finland

Malignant neoplasm of brain, Cerebelli

+∞

12.5

9470/3-C71.6

ICD-O-3

Medulloblastoma, NOS, of cerebellum, NOS

+∞

12.5

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

12.5

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

12.5

19100

ICD-8 Finland

Malignant neoplasm of brain, Lobi frontalis

+∞

12.5

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

12.5

N02AA01

ATC

morphine; systemic, rectal

4.3

12.5

L02BG06

ATC

exemestane; oral

130.8

12.4

X76

ICPC

Malignant neoplasm breast female

130.8

12.4

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

130.8

12.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

130.8

12.4

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

130.8

12.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

130.8

12.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

12.4

197

1147

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

11.7

12.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

12.3

301

1971

OAA67, ,

SPAT

0.5

12.2

108

2104

F80.1

ICD-10 Finland

Expressive language disorder

4.3

12.2

SPAT1153

SPAT

Removal of sutures

1.5

12.2

529

3919

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

12.2

109

522

AAF15

NOMESCO Finland

Ventriculoatrial shunt

16.0

12.1

N05BA01

ATC

diazepam; systemic, rectal

1.7

12.1

245

1529

C01DA14

ATC

isosorbide mononitrate; oral

0.5

12.0

125

2308

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.6

12.0

248

3787

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

11.9

427

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

11.9

376

ZXD35

NOMESCO Finland

Usual procedure

2.5

11.9

285

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

14.7

11.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

11.8

436

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

65.3

11.6

L13

ICPC

Hip symptom/complaint

0.5

11.6

143

2508

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

23.0

11.6

C10AA05

ATC

atorvastatin; oral

0.7

11.6

501

6569

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

11.5

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

11.5

D43

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of brain and central nervous system

+∞

11.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

11.5

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

11.5

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

11.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

11.5

9380/3-C71.1

ICD-O-3

Glioma, malignant of frontal lobe

+∞

11.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

11.5

ZX131

NOMESCO Finland

Intrathecal

+∞

11.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

11.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.5

OAA41

NOMESCO Finland

Health check based on individual needs

120.6

11.4

9421/1-C71.6

ICD-O-3

Pilocytic astrocytoma of cerebellum, NOS

120.6

11.4

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

11.4

165

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

11.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

11.3

201

3194

EB1VA, ,

NOMESCO Finland

0.5

11.3

132

2356

N29

ICPC

Neurological sympt/complt other

3.0

11.3

166

WX002

NOMESCO Finland

Sedation and analgesia

1.6

11.2

330

2251

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.2

164

932

G41.0

ICD-10 Finland

Grand mal status epilepticus

17.1

11.2

A07AA02

ATC

nystatin; oral

2.1

11.0

104

509

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

43.5

10.9

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.0

10.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

10.7

OAB42, ,

SPAT

0.5

10.7

1745

SPAT1290

SPAT

Preparation of deceased person

60.3

10.6

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

60.3

10.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

60.3

10.6

R83

ICPC

Respiratory infection other

0.6

10.5

230

3481

N05AD01

ATC

haloperidol; systemic

2.4

10.4

297

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

110.6

10.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

110.6

10.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

110.6

10.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

10.4

197

Kela drug reimbursment

Sunitinib

+∞

10.4

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

10.4

C70.9

ICD-10 Finland

Malignant neoplasm: Meninges, unspecified

+∞

10.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

10.4

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

10.4

AA003

NOMESCO Finland

Adjuvant radiotherapy of brain

+∞

10.4

1916A

ICD-9 Finland

Malignant neoplasm of brain, Cerebellum[PIKKUAIVOJEN SYÖPÄ, ASTROCYTOMA (GR I-II)]

+∞

10.4

C71.63

ICD-10 Finland

Malignant tumor of cerebellum grade IV glioma

+∞

10.4

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

10.4

C72.00

ICD-10 Finland

Malignant tumor of the spinal cord without histology

+∞

10.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

10.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

10.4

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

32.7

10.3

AAF50

NOMESCO Finland

Third ventriculostomy

32.7

10.3

N03AX15

ATC

zonisamide; oral

10.6

10.3

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.9

10.3

NG1AA, ,

SPAT

0.3

10.2

919

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

10.2

290

4142

A06AH03

ATC

naloxegol; oral

7.9

10.1

OAB48, ,

SPAT

0.5

10.1

109

1995

WZC00, ,

SPAT

0.5

10.0

105

1941

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.6

10.0

172

2760

L02BG03

ATC

anastrozole; oral

40.3

10.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

9.9

323

AAK00

NOMESCO Finland

Cranioplasty

16.8

9.9

I10

ICD-10 Finland

Essential (primary) hypertension

0.7

9.9

850

10055

XX9XW, ,

NOMESCO Finland

5.2

9.8

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.6

9.8

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

20.1

9.8

L15

ICPC

Knee symptom/complaint

0.6

9.8

240

3544

Z50.5

ICD-10 Finland

Speech therapy

3.3

9.7

106

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

9.7

115

611

S18

ICPC

Laceration/cut

1.3

9.7

820

6755

WPA13

NOMESCO Finland

Palliative consultation

13.4

9.7

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.3

9.6

R74

ICPC

Upper respiratory infection acute

0.7

9.6

332

4570

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

9.6

309

R01AD12

ATC

fluticasone furoate; nasal

0.7

9.5

308

4297

SPAT1229

SPAT

Assessment of need for aid

1.8

9.5

135

761

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

9.5

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

9.5

808

C50

ICD-10 Finland

Malignant neoplasm of breast

100.5

9.4

C90.0

ICD-10 Finland

Multiple myeloma

100.5

9.4

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

100.5

9.4

R03DC03

ATC

montelukast; oral

0.5

9.4

119

2078

9400/3-C71.0

ICD-O-3

Astrocytoma, NOS, of cerebrum

+∞

9.4

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

9.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

9.4

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

9.4

9380/3-C71.2

ICD-O-3

Glioma, malignant of temporal lobe

+∞

9.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

9.4

19101

ICD-8 Finland

Malignant neoplasm of brain, Lobi temporalis

+∞

9.4

C72.09

ICD-10 Finland

Malignant tumor of the spinal cord other histology

+∞

9.4

WW402

NOMESCO Finland

Leucoferesis

+∞

9.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

9.4

9391/3-C71.7

ICD-O-3

Ependymoma, NOS, of brain stem

+∞

9.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

9.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

9.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

9.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

9.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

9.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

9.4

8000/3-C71.1

ICD-O-3

Neoplasm, malignant of frontal lobe

+∞

9.4

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

C71.71

ICD-10 Finland

Malignant tumor of the brainstem grade II glioma

+∞

9.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

9.4

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

21.8

9.3

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.3

9.3

313

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

9.3

499

3818

PA6AD

NOMESCO Finland

CT of neck arteries

2.2

9.3

378

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

10.7

9.3

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

9.2

145

2386

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

9.2

122

2104

C07AB07

ATC

bisoprolol; oral

0.7

9.1

626

7691

R05

ICPC

Cough

0.6

9.1

237

3459

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.5

9.1

1782

A10BK03

ATC

empagliflozin; oral

0.5

9.1

1326

D32.05

ICD-10 Finland

Cerebral meninges

15.6

9.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

15.6

9.0

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

9.1

9.0

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

36.8

9.0

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

36.8

9.0

207

Kela drug reimbursment

Chronic arrhythmias

0.6

9.0

119

2054

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

7.5

8.9

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

8.8

107

574

SPAT1109

SPAT

Analgesia with portable analgesic pump

10.7

8.8

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.8

8.8

151

N06DX01

ATC

memantine; oral

0.4

8.7

992

A10AB05

ATC

insulin aspart; parenteral

1.7

8.7

150

896

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.6

8.6

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.0

8.5

1CX01, ,

NOMESCO Finland

90.4

8.4

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

90.4

8.4

N02BE01

ATC

paracetamol; systemic, rectal

1.4

8.4

1714

15903

9445/3-C71.9

ICD-O-3

Glioblastoma, IDH-mutant of brain, NOS

+∞

8.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

8.3

3AA13, ,

NOMESCO Finland

+∞

8.3

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

8.3

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

8.3

C71.41

ICD-10 Finland

Malignant tumor of occipital lobe grade II glioma

+∞

8.3

8000/3-C71.2

ICD-O-3

Neoplasm, malignant of temporal lobe

+∞

8.3

C71.73

ICD-10 Finland

Malignant tumor of the brain stem grade IV glioma

+∞

8.3

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

8.3

C71.5

ICD-10 Finland

Malignant neoplasm: Cerebral ventricle

+∞

8.3

ZX004, ,

NOMESCO Finland

+∞

8.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

8.3

1919X

ICD-9 Finland

Malignant neoplasm of brain, Brain, unspecified[TARKEMMIN MÄÄRITTELEMÄTÖN AIVOSYÖPÄ,EI HIST VAHV]

+∞

8.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

8.3

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

+∞

8.3

C71.62

ICD-10 Finland

Malignant tumor of cerebellum grade III glioma

+∞

8.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

8.3

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

8.3

AAA50

NOMESCO Finland

Intracranial endoscopy

+∞

8.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

8.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

8.3

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

8.3

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

8.2

145

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.6

8.2

185

2793

L08

ICPC

Shoulder symptom/complaint

0.7

8.2

222

3221

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

14.5

8.2

OAA80, ,

SPAT

0.5

8.1

1248

M54.5

ICD-10 Finland

Low back pain

0.7

8.1

418

5392

ZX100

NOMESCO Finland

Oral

3.5

8.1

XX2XW

NOMESCO Finland

Other teleradiological consultation

8.9

8.0

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

8.0

1360

A86

ICD-10 Finland

Unspecified viral encephalitis

6.3

8.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

7.9

335

ZX121

NOMESCO Finland

Central venous catheter

13.1

7.9

Z31.5

ICD-10 Finland

Genetic counselling

2.1

7.9

356

SDA03

NOMESCO Finland

Periodontal treatment

0.7

7.8

470

5922

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.9

7.7

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.3

7.7

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

7.7

186

L17

ICPC

Foot/toe symptom/complaint

0.7

7.7

332

4415

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.6

7.7

146

2293

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

7.7

134

EB4VA, ,

NOMESCO Finland

0.6

7.6

136

2169

301

Kela drug reimbursment

Growth hormone

18.4

7.6

1XC02, ,

NOMESCO Finland

6.7

7.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.6

7.6

128

2069

ZXC96

NOMESCO Finland

Robot assisted procedure

6.2

7.5

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.4

7.5

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.3

7.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

7.5

130

778

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.7

7.5

341

4499

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

7.5

113

1882

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

7.5

489

SFA20

NOMESCO Finland

Two-surface restoration

0.8

7.4

803

9357

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.5

7.4

177

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

80.4

7.4

D33.04

ICD-10 Finland

Temporal lobe

80.4

7.4

D33.1

ICD-10 Finland

Benign neoplasm: Brain, infratentorial

80.4

7.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

80.4

7.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

80.4

7.4

AA5GG

NOMESCO Finland

Extensive functional MRI examination of brain withhigh intensity magnet

80.4

7.4

FM1FN

NOMESCO Finland

Heart function isotope examination

80.4

7.4

N80

ICPC

Head injury other

2.4

7.4

220

ZZR00

NOMESCO Finland

Flap of skin

6.5

7.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

7.4

202

1353

DFF20

NOMESCO Finland

Audiometry for children

13.4

7.4

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.6

7.4

154

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

7.4

117

1923

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

7.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

7.3

AA5AK

NOMESCO Finland

Brain spectroscopy

+∞

7.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

7.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

9382/3-C71.2

ICD-O-3

Oligoastrocytoma, NOS, of temporal lobe

+∞

7.3

C71.04

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles ependyoma

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

7.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

7.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

7.3

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

7.3

YA1WD, ,

NOMESCO Finland

+∞

7.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

7.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

7.3

1BC01, ,

NOMESCO Finland

+∞

7.3

1911A

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]

+∞

7.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

7.3

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

7.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

7.3

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

+∞

7.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

7.3

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

7.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

7.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

7.3

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

7.3

1912X

ICD-9 Finland

Malignant neoplasm of brain, Temporal lobe[AIVOJEN OHIMOLOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUS]

+∞

7.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

7.3

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

7.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

7.3

9400/3-C71.3

ICD-O-3

Astrocytoma, NOS, of parietal lobe

+∞

7.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

7.3

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

6.3

7.2

K22

ICPC

Risk factor cardiovascular disease

0.3

7.2

681

A10BA02

ATC

metformin; oral

0.7

7.1

319

4227

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

30.1

7.1

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

30.1

7.1

WPA44

NOMESCO Finland

Nursing home for palliative care

20.1

7.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

20.1

7.1

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

12.1

7.1

D82

ICPC

Teeth/gum disease

0.7

7.0

430

5418

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.1

6.9

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.3

6.9

209

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

6.8

968

10959

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.7

6.8

217

3054

XX4AW, ,

NOMESCO Finland

9.3

6.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

40.2

6.8

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

40.2

6.8

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.6

6.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

16.7

6.7

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

6.7

1168

R05

ICD-10 Finland

Cough

0.7

6.7

199

2842

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

6.7

110

649

WZC30, ,

SPAT

0.5

6.7

1086

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

22.6

6.7

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

22.6

6.7

2132

FHL

Ventricular operators sunt

22.6

6.7

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

6.6

163

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

5.9

6.6

S12

ICPC

Insect bite/sting

0.5

6.6

1002

I50.0

ICD-10 Finland

Congestive heart failure

0.4

6.6

920

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.3

6.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

6.6

114

683

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.9

6.6

424

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

8.7

6.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

6.5

398

3093

ZXC86

NOMESCO Finland

Use of endoscopic device

6.2

6.5

B01AB04

ATC

dalteparin; parenteral

1.9

6.4

377

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

70.1

6.4

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

70.1

6.4

B72

ICPC

Hodgkin Lymphoma

70.1

6.4

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

70.1

6.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

70.1

6.4

JLC30

NOMESCO Finland

Pancreatoduodenectomy

70.1

6.4

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

3.4

6.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

6.3

379

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.5

6.3

1273

R03AK07

ATC

formoterol and budesonide; inhalant

0.7

6.3

195

2765

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

6.3

741

8607

R5110, ,

SPAT

1.6

6.3

141

903

S77

ICPC

Malignant neoplasm of skin

18.1

6.3

L02AE04

ATC

triptorelin; parenteral

+∞

6.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.3

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

6.3

9424/3-C71.9

ICD-O-3

Pleomorphic xanthoastrocytoma, NOS, of brain, NOS

+∞

6.3

1911F

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,MUU]

+∞

6.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

6.3

9382/3-C71.3

ICD-O-3

Oligoastrocytoma, NOS, of parietal lobe

+∞

6.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

6.3

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

6.3

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

6.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

2141

FHL

Stereotactic biopsy of the brain

+∞

6.3

C71.66

ICD-10 Finland

Malignant tumor of the cerebellum medullobastoma

+∞

6.3

C71.05

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles primary neuroectodermal tumor

+∞

6.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

6.3

C75.3

ICD-10 Finland

Malignant neoplasm: Pineal gland

+∞

6.3

L01XE04

ATC

[U] sunitinib

+∞

6.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.3

C72.01

ICD-10 Finland

Malignant tumor of the spinal cord grade II glioma

+∞

6.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

6.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

6.3

9445/3-C71.1

ICD-O-3

Glioblastoma, IDH-mutant of frontal lobe

+∞

6.3

9391/3-C72.0

ICD-O-3

Ependymoma, NOS, of spinal cord

+∞

6.3

9401/3-C71.3

ICD-O-3

Astrocytoma, anaplastic, NOS, of parietal lobe

+∞

6.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.3

AAM10

NOMESCO Finland

Excision of intracerebral abscess

+∞

6.3

19105

ICD-8 Finland

Malignant neoplasm of brain, Hypothalami

+∞

6.3

L02BX03

ATC

abiraterone; oral

+∞

6.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

6.3

1AC01, ,

NOMESCO Finland

+∞

6.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.3

WPA43, ,

SPAT

26.7

6.2

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

26.7

6.2

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

7.0

6.2

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

7.0

6.2

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

6.2

310

4044

SFA10

NOMESCO Finland

One-surface restoration

0.8

6.2

753

8719

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.1

6.2

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

5.0

6.2

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

6.2

110

665

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.3

6.1

G03.9

ICD-10 Finland

Meningitis, unspecified

7.7

6.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

6.1

287

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

8.6

6.1

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.1

6.0

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

10.0

6.0

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

388

48.18

307.65

1.7

2.0

—

(4035726) Immunohistochemistry procedure

867

454

31.50

307.65

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

270

+∞

288.23

1.0

0.0

—

(3003396) Base excess in Arterial blood by calculation

744

1924

5.40

280.52

7.8

8.4

1.10

1.07

mmol/l

0.09

589

1586

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

742

1933

5.35

276.96

8.0

8.4

4.97

5.09

kpa

3.20

714

1862

(3027801) Oxygen [Partial pressure] in Arterial blood

742

1933

5.35

276.96

8.0

8.4

17.33

11.67

kpa

81.10

714

1862

(3019977) pH of Arterial blood

742

1936

5.34

276.39

8.0

8.4

7.42

0.86

485

1099

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

140

93.58

267.92

1.1

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

823

2544

4.64

244.62

2.1

2.2

27.23

29.65

24.33

803

2473

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

119

66.27

216.61

1.5

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

191

181

11.49

177.74

2.1

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

262

378

7.76

176.02

2.0

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

276

422

7.36

176.00

2.1

1.4

2364.99

1424.01

e6/l

0.48

219

343

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

273

418

7.34

173.80

2.0

1.3

53.62

33.21

e6/l

0.39

210

325

(40768804) Tissue Pathology biopsy report

1142

5373

3.42

169.99

3.0

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

158

+∞

166.90

1.1

0.0

—

(3044640) Blood type and Crossmatch panel - Blood

1058

4865

3.33

161.43

2.8

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

187

199

10.20

160.19

1.9

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

132

16.11

152.33

2.5

2.6

55.96

52.61

umol/l

0.36

117

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

253

429

6.56

145.51

1.8

1.2

3.60

3.84

mmol/l

1.97

247

410

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1428

8219

3.23

141.72

14.1

4.1

10.06

12.26

umol/l

14.05

1399

7752

(3033658) Prothrombin time (PT) actual/Normal

902

4055

3.12

138.13

4.4

3.9

94.28

88.39

12.62

881

3961

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

849

3715

3.14

135.88

2.6

2.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1304

7364

2.98

129.26

9.3

6.2

1.19

1.21

mmol/l

13.50

1270

6718

(3002173) Hemoglobin [Mass/volume] in Arterial blood

495

1606

3.71

128.01

9.4

9.3

127.06

123.24

g/l

4.05

482

1573

(3016502) Oxygen saturation in Arterial blood

504

1722

3.52

119.73

9.5

8.8

97.78

95.11

23.49

488

1665

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1370

8266

2.84

114.18

9.8

6.5

1.20

1.21

mmol/l

9.76

1239

7141

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1047

5683

2.66

104.89

2.9

2.2

173.61

236.99

u/l

1.52

1029

5382

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

11.96

101.39

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1525

10071

2.81

100.57

9.3

4.9

6.73

mmol/l

0.03

1500

9507

(3014007) Fractional oxyhemoglobin in Arterial blood

356

1078

3.76

100.35

7.6

11.1

96.00

93.51

13.78

356

1072

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

121

135

9.44

99.52

1.9

1.2

2.43

2.24

mmol/l

0.46

115

128

(3013650) Neutrophils [#/volume] in Blood by Automated count

1443

9304

2.70

99.22

19.9

7.0

4.18

4.24

e9/l

0.39

1259

7990

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1211

7242

2.56

96.39

3.3

2.5

—

estimate

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

12.77

93.71

2.1

2.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

592

2572

2.80

90.04

4.6

3.0

0.83

mmol/l

0.96

571

2401

(3011412) CD3 cells [#/volume] in Blood

104

115

9.46

86.02

2.0

2.5

1023.24

1344.02

e6/l

2.37

103

(3023410) Appearance of Cerebral spinal fluid

131

195

7.09

84.54

2.0

1.5

—

(3019069) Monocytes/Leukocytes in Blood

1247

7897

2.40

82.59

11.0

6.2

8.80

8.85

0.23

1214

7382

(3006504) Eosinophils/Leukocytes in Blood

1241

7887

2.37

80.87

11.0

6.1

1.97

2.95

47.86

1205

7366

(3022096) Basophils/Leukocytes in Blood

1237

7897

2.35

79.09

11.0

6.2

0.51

0.68

23.58

1203

7363

(3036481) Cortisol [Moles/volume] in Serum or Plasma

418

1605

3.00

78.93

2.8

1.9

333.53

366.21

nmol/l

1.06

400

1475

(3002030) Lymphocytes/Leukocytes in Blood

1250

8100

2.31

75.95

11.3

6.1

23.66

28.08

37.11

1221

7664

(3001604) Monocytes [#/volume] in Blood

1301

8663

2.29

72.78

10.9

6.0

0.57

0.59

e9/l

1.71

1110

7421

(3000991) Gas panel - Venous blood

391

1510

2.95

72.63

8.0

9.7

—

(3018010) Neutrophils/Leukocytes in Blood

1226

7981

2.26

72.27

11.0

6.1

61.36

57.12

25.88

1203

7609

(3006315) Basophils [#/volume] in Blood

1300

8683

2.27

71.76

11.0

6.0

0.03

0.04

e9/l

24.70

1111

7440

(3023368) Bacteria identified in Blood by Culture

804

4424

2.31

71.03

5.2

4.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

283

924

3.38

69.86

11.8

16.95

16.08

5.07

269

895

(3019198) Lymphocytes [#/volume] in Blood

1308

8866

2.23

68.11

11.2

6.1

1.55

1.90

e9/l

20.65

1125

7776

(3015377) Calcium [Moles/volume] in Serum or Plasma

910

5342

2.23

68.03

8.7

2.1

2.35

mmol/l

0.15

865

4748

(3013115) Eosinophils [#/volume] in Blood

1315

8982

2.21

66.48

11.7

6.2

0.13

0.20

e9/l

57.31

1129

7819

(3018418) pH of Serum or Plasma

833

4764

2.23

65.94

4.8

3.4

7.41

7.40

4.81

592

3395

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

10.61

65.24

3.3

2.7

27.90

30.50

umol/l

0.82

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

9.67

62.71

2.2

1.2

61.64

58.75

0.12

(3024561) Albumin [Mass/volume] in Serum or Plasma

1102

7147

2.12

62.06

6.2

4.2

34.85

36.11

g/l

10.27

1058

6650

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1416

17380

0.45

61.45

4.5

5.8

2.81

2.69

mmol/l

5.27

1308

16302

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1386

17143

0.45

61.29

4.1

5.2

4.70

4.58

mmol/l

4.21

1280

16137

(3032080) INR in Blood by Coagulation assay

1156

7665

2.11

61.01

8.9

16.2

1.12

1.29

inr

29.89

999

6411

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1380

17043

0.46

58.92

4.1

5.1

1.43

mmol/l

0.02

1279

15937

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

383

7527

0.40

57.76

1.9

1.38

1.37

mmol/l

0.07

329

6402

(3014111) Lactate [Moles/volume] in Serum or Plasma

364

1547

2.63

55.21

7.1

8.4

1.35

1.40

mmol/l

0.38

356

1517

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

7.64

54.04

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.74

53.49

2.0

1.1

22.65

19.71

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1322

16379

0.49

51.03

5.2

6.4

38.70

39.51

mmol/mol

2.92

1237

15431

(3009466) Valproate [Moles/volume] in Serum or Plasma

127

298

4.47

49.88

3.4

5.8

355.88

360.99

umol/l

0.14

119

265

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.52

47.18

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

758

4616

2.00

47.14

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

7.24

46.31

1.1

1.65

1.11

u/l

1.89

(21494814) CD8 cells/Lymphocytes in Specimen

11.42

44.97

1.7

2.1

37.57

24.55

4.76

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

178

5.30

44.35

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

96.13

42.93

1.3

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

7.22

42.90

2.1

2.4

480.82

508.53

e6/l

0.13

(3020779) Urea [Moles/volume] in Serum or Plasma

331

1510

2.41

42.46

5.0

7.5

6.75

9.82

mmol/l

15.66

312

1444

(3019060) Gas panel - Arterial blood

250

1006

2.68

41.71

10.6

4.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

7.10

41.63

2.1

2.4

154.81

218.96

e6/l

1.93

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1339

16250

0.53

41.47

3.7

4.3

1.30

mmol/l

0.16

1239

15062

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

504

2794

2.05

39.68

2.2

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

254

1061

2.58

39.20

13.8

6.7

25.32

24.52

mmol/l

2.88

237

1019

(3039000) Anion gap in Blood by calculation

121

328

3.85

39.10

16.4

6.9

10.70

11.66

mmol/l

2.62

106

297

(3018572) Chloride [Moles/volume] in Blood

121

329

3.84

38.93

16.4

6.9

105.69

105.19

mmol/l

0.38

106

298

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.52

36.97

1.2

1.1

686.14

99.66

ng/l

0.71

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

7.52

36.97

2.5

39.28

45.60

1.44

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

406

2127

2.12

36.92

2.0

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

131

5.57

36.87

1.1

1.2

83.08

36.95

mg/l

1.17

113

(40768795) Lymph node Pathology biopsy report

13.16

36.61

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

125

5.67

36.54

1.1

564.31

259.19

mg/l

1.33

113

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

177

638

2.93

36.23

1.9

2.3

449.51

443.45

ug/l

0.01

169

603

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1577

12777

1.90

36.01

16.0

5.9

74.51

77.04

u/l

1.59

1543

11987

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

387

2009

2.13

35.96

2.1

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

318

1528

2.27

35.82

4.8

2.5

248.13

231.42

u/l

1.79

307

1435

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

198

763

2.76

35.78

2.8

1.5

32.68

2.72

ug/l

0.64

149

567

(3021589) Normoblasts [#/volume] in Blood

1051

7606

1.75

34.60

19.7

9.9

0.00

e9/l

2.97

828

6188

(3017181) Myelocytes/Leukocytes in Blood

293

1399

2.27

33.37

4.8

4.2

1.71

0.66

11.06

176

306

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.81

33.21

1.4

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

294

3.70

32.36

4.1

6.0

229.67

414.89

iu/ml

0.54

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

521

3107

1.90

32.33

4.1

2.1

2.45

2.44

mmol/l

0.68

483

2723

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

137

460

3.11

31.71

3.4

4.2

0.41

0.36

iu/ml

0.70

260

(36304419) Bacteria [Presence] in Urine

673

4399

1.77

30.71

3.2

3.0

0.00

0.24

estimate

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

102

5.71

30.58

1.4

1.2

0.50

0.53

ratio

0.68

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1420

16579

0.57

30.40

4.5

5.1

5.88

5.97

mmol/l

1.84

1306

15296

(3030467) Casts [#/volume] in Urine by Automated count

694

4603

1.75

29.95

3.2

3.1

0.45

0.38

e6/l

0.27

522

3349

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

126

5.12

29.95

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

9.35

29.19

5.1

2.4

2.00

0.86

2.26

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

214

4.00

28.75

5.6

7.0

9.76

11.66

mg/l

3.31

200

(3007930) Methemoglobin/Hemoglobin.total in Blood

171

684

2.63

28.60

14.3

4.9

1.01

0.86

5.46

157

648

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

198

866

2.42

27.41

1.5

—

(3045142) Bone marrow Pathology biopsy report

6.59

27.31

1.3

—

(3047181) Lactate [Moles/volume] in Blood

136

502

2.83

26.56

15.2

5.8

1.71

1.29

mmol/l

2.03

118

448

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

4.87

26.50

2.9

2.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

177

751

2.48

26.16

14.1

4.7

1.56

1.68

1.00

163

714

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.54

26.06

1.1

—

(1761868) Lipid panel - Serum or Plasma

444

6841

0.56

25.94

2.9

3.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

265

1346

2.11

25.53

4.3

4.0

1.32

0.50

4.77

152

299

(3002582) Erythrocytes [#/volume] in Urine

762

5394

1.64

24.70

3.3

3.2

28.51

76.97

e6/l

2.60

586

4088

(40758558) Short blood count panel - Blood

719

5024

1.65

24.49

14.1

4.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

123

451

2.83

24.32

2.6

2.9

3.13

3.54

g/l

2.68

123

427

(3012516) Albumin [Mass/volume] in Urine

381

6038

0.55

24.12

3.0

3.5

64.06

44.41

mg/l

0.89

241

3929

(3009508) Creatinine [Moles/volume] in Urine

420

6473

0.56

24.05

3.0

3.5

7.94

7.84

mmol/l

0.16

350

5533

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

121

444

2.83

23.89

1.8

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

261

1361

2.05

23.35

4.9

4.2

0.25

0.04

5.09

145

266

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

155

4.16

23.27

4.3

2.5

17.94

19.65

nmol/l

0.55

142

(3008757) Leukocyte morphology finding [Identifier] in Blood

114

4.74

23.17

3.8

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

8.05

23.04

2.4

2.5

0.33

0.36

e9/l

0.10

(3026008) Bacteria identified in Urine by Culture

691

4844

1.63

22.91

3.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

399

6116

0.57

21.84

3.7

4.2

9.72

7.81

mg/mmol

0.46

239

3878

(3003181) Sodium [Moles/volume] in Urine

302

3.10

21.49

1.5

1.4

83.70

62.31

mmol/l

3.25

242

(3012501) Base excess in Blood by calculation

313

3.06

21.44

3.5

4.3

2.36

2.50

mmol/l

0.21

195

(3005719) IgG [Mass/volume] in Serum or Plasma

235

1218

2.04

21.30

3.1

2.5

8.88

10.79

g/l

12.89

223

1136

(3026782) Osmolality of Urine

484

3153

1.69

21.06

3.0

2.7

531.15

536.19

mosm/kgh2o

0.20

435

2740

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

152

3.96

20.50

1.7

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

135

4.16

20.40

1.5

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

103

383

2.78

19.85

2.1

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

101

376

2.77

19.42

2.0

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

409

2605

1.71

19.16

2.8

3.0

2.48

2.40

e6/l

0.06

200

1230

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

202

1032

2.06

18.99

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

240

3.20

18.84

2.2

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

356

2195

1.75

18.71

5.2

5.9

1.01

1.04

mmol/l

1.49

339

2029

(3036489) Thrombin time

141

628

2.33

18.66

2.4

2.3

20.84

20.85

0.01

130

561

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

301

2.94

18.53

2.5

2.3

35.59

28.91

u/ml

0.12

249

(3010813) Leukocytes [#/volume] in Blood

1743

18851

0.59

18.39

42.5

20.8

6.98

6.73

e9/l

4.82

1709

18360

(3000963) Hemoglobin [Mass/volume] in Blood

1743

18850

0.59

18.36

43.0

20.9

133.10

137.39

g/l

28.07

1734

18623

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

30.32

18.34

1.5

2.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

359

2.75

18.31

1.7

3.1

29.30

36.33

umol/l

1.51

329

(3026361) Erythrocytes [#/volume] in Blood

1743

18845

0.59

18.21

42.5

20.7

4.39

4.55

e12/l

29.80

1709

18354

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1743

18845

0.59

18.21

43.3

21.2

39.60

41.32

5.76

1731

18609

(3035941) MCH [Entitic mass]

1743

18844

0.59

18.18

42.4

20.7

30.62

30.35

8.44

1729

18616

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1743

18842

0.59

18.12

42.5

20.7

91.44

90.91

5.48

1731

18613

(3007461) Platelets [#/volume] in Blood

1743

18835

0.59

17.91

42.5

20.8

238.79

247.60

e9/l

5.81

1711

18415

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.00

17.83

1.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.94

17.58

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

189

3.40

17.56

2.1

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

433

2868

1.64

17.28

2.8

1.07

1.22

e6/l

0.24

227

1503

(3008295) Osmolality of Serum or Plasma

189

3.35

16.87

1.6

1.5

282.30

278.22

mosm/kgh2o

0.63

137

(3031040) Bacteria [#/volume] in Urine by Automated count

1292

10854

1.48

16.78

4.7

4.4

2722.19

1890.66

e6/l

0.16

155

(3021879) Hepatitis B virus core Ab [Presence] in Serum

222

1226

1.91

16.65

1.5

—

(3025159) Blasts/Leukocytes in Blood

243

1387

1.85

16.44

5.0

4.4

0.11

0.01

2.11

124

246

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

348

2.66

16.11

1.5

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

166

3053

0.51

16.08

1.2

1.3

10.95

9.91

u/ml

0.08

1190

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1421

15976

0.67

16.01

5.0

5.1

1.76

1.91

mu/l

3.89

1324

14823

(3018095) Leukocytes [#/volume] in Urine

806

6231

1.47

15.68

4.0

3.8

36.08

99.93

e6/l

5.43

594

4297

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

292

1797

1.72

15.26

2.7

2.5

6.37

7.48

umol/l

0.69

252

1570

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

129

605

2.21

15.11

2.0

1.7

1.06

1.42

ug/l

0.30

109

534

(1616796) Gas panel - Central venous blood

347

2.51

13.66

3.2

3.8

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

13.55

1.1

0.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

130

3.51

13.35

1.9

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

199

3282

0.57

13.10

1.3

25.57

33.10

iu/ml

0.57

968

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

494

2.23

13.05

2.5

1.5

6.37

7.47

u/l

0.64

393

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

189

3.02

12.94

2.1

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.15

12.69

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

118

574

2.12

12.63

6.3

3.6

166.90

305.68

mg/l

3.05

225

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

282

2.61

12.62

1.4

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

13.24

12.42

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

190

1096

1.81

12.36

1.9

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

283

1830

1.63

12.13

5.6

3.7

5.75

5.85

kpa

1.17

274

1780

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.80

12.01

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.88

11.80

2.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

2.40

11.76

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

210

2.76

11.28

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

210

2.76

11.28

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

210

2.76

11.28

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

210

2.76

11.28

1.6

1.5

—

(3002032) Base excess in Venous blood by calculation

274

1790

1.61

11.24

5.5

3.7

2.05

1.82

mmol/l

0.69

241

1550

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

828

6729

1.38

11.07

3.9

3.8

32.67

69.12

ng/l

2.19

647

4681

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.76

11.01

1.2

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

227

2.64

10.76

1.6

1.3

—

(3012544) pH of Venous blood

278

1846

1.58

10.62

5.6

3.8

7.39

7.38

1.49

169

1066

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

105

3.47

10.58

1.5

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

487

2.08

10.33

1.5

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

100

496

2.07

10.21

2.3

3.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

124

665

1.92

10.16

2.3

1.4

20.53

23.26

iu/l

0.46

103

564

(3000850) Epithelial cells [#/volume] in Urine

493

3720

1.42

10.03

2.9

2.6

5.19

5.72

e6/l

0.35

459

3364

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

247

1624

1.59

9.82

4.6

3.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

20.12

9.80

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

280

1902

1.54

9.65

1.6

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.20

9.64

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

348

2.23

9.53

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

348

2.23

9.53

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

172

2.77

9.47

1.4

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

930

10815

0.75

9.34

2.9

3.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

466

3523

1.41

9.30

3.4

4.0

83.34

541.69

ng/l

10.88

358

2762

(3001122) Ferritin [Mass/volume] in Serum or Plasma

663

8092

0.74

9.30

2.7

3.1

187.38

117.09

ug/l

3.16

611

7567

(3002256) Pathology report gross observation

211

1354

1.62

9.28

1.4

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

235

1557

1.57

9.03

5.7

3.2

4.75

4.59

kpa

0.51

228

1509

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

24.11

8.91

7.5

1.0

19.05

12.02

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1193

13362

0.76

8.89

4.5

4.1

14.71

14.76

pmol/l

0.20

1111

12297

(3042936) Bacteria identified in Isolate by Culture

327

2334

1.47

8.86

1.9

2.1

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

7.98

8.85

2.0

1.1

57.45

52.00

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

108

3.18

8.78

2.2

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.49

8.65

1.8

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

337

2437

1.45

8.52

1.6

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1480

0.50

8.51

1.6

1.7

3.46

3.51

mmol/l

0.16

1044

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

184

1171

1.63

8.37

5.9

3.0

1.22

1.23

mmol/l

1.26

172

983

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

8.34

1.0

0.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

8.34

1.4

0.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.00

8.34

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.93

8.15

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.77

8.11

1.3

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

696

5712

1.32

8.07

5.0

2.8

30.98

35.84

u/l

0.93

671

5384

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

191

1240

1.59

8.00

2.1

2.4

9.66

19.79

au/ml

—

127

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

655

7888

0.76

7.97

2.3

2.5

73.93

76.85

nmol/l

1.93

605

7117

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.50

7.82

1.8

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

121

1995

0.58

7.71

1.8

2.0

3.43

3.57

ratio

0.66

105

1561

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1147

12808

0.77

7.68

4.0

4.3

11.59

11.08

mm/h

0.60

1080

12011

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

172

1102

1.61

7.62

6.0

3.9

24.85

24.19

mmol/l

2.60

166

1090

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1716

18139

0.72

7.62

20.7

10.2

31.86

26.77

u/l

17.09

1693

17568

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.61

7.58

1.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

658

7879

0.76

7.55

2.0

2.1

95.29

95.36

pmol/l

0.01

377

4182

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.06

7.53

1.1

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.92

7.43

1.6

3.3

34.71

44.89

1.12

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1740

18338

0.72

7.39

35.3

17.5

72.32

78.43

umol/l

12.25

1728

18097

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.67

7.38

1.1

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

347

2.05

7.25

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.32

7.24

1.9

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

173

1126

1.58

7.18

1.2

1.3

39.36

50.31

au/ml

—

(40768793) Breast Pathology biopsy report

111

2.91

7.17

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

100

562

1.82

7.16

1.9

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

691

0.34

7.06

1.2

1.46

1.50

g/l

0.29

691

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

290

2.14

7.05

1.6

1.3

—

(40758292) HTLV I+II Ab panel - Serum

8.80

7.04

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.71

6.91

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.71

6.81

1.6

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

3.73

6.64

3.3

6.6

7.70

7.67

0.01

(3048689) Calprotectin [Mass/mass] in Stool

152

2284

0.64

6.55

2.5

2.7

213.74

146.00

ug/g

0.66

127

1850

(3052851) Hemolysis interference index of Serum or Plasma

453

1.87

6.55

4.0

3.4

2.93

1.87

index

0.84

233

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

327

2.02

6.50

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

280

2.10

6.47

1.7

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

215

2.26

6.44

2.1

1.5

0.23

0.34

nmol/l

1.75

180

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

515

6273

0.76

6.44

4.2

3.9

2.67

1.87

ug/l

1.23

461

5686

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

3.41

6.42

4.2

3.2

0.95

1.56

ug/l

0.58

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

195

1337

1.50

6.42

1.8

2.2

0.24

0.21

g/l

4.47

183

1231

(40760892) CBC W Ordered Manual Differential panel - Blood

474

3788

1.32

6.40

7.6

4.5

—

(3035933) Granulocytes/Leukocytes in Blood

323

2.01

6.35

4.2

3.2

57.47

57.43

0.00

323

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

271

2.10

6.22

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

401

5014

0.75

6.00

3.6

3.7

22.57

24.03

1.13

190

2203

(40765096) Chromosome analysis panel by Banding

6.03

5.99

1.2

1.0

—

(21494755) Public health laboratory ask at order entry panel

104

1670

0.60

5.97

1.3

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

154

1030

1.53

5.71

3.6

4.7

2.03

1.76

mmol/l

0.51

126

743

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

125

1903

0.64

5.71

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

317

4073

0.74

5.69

1.3

2.35

1.64

u/ml

0.34

1135

(3028026) IgM [Mass/volume] in Serum or Plasma

145

958

1.55

5.68

2.4

1.5

1.38

1.19

g/l

0.41

140

893

(3020191) Ethanol [Moles/volume] in Serum or Plasma

152

2.39

5.56

1.6

1.3

1.03

1.31

promille

0.45

117

(3005322) IgE [Units/volume] in Serum or Plasma

1246

0.56

5.51

1.4

1.3

365.91

253.41

u/ml

0.46

1163

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.48

5.45

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.09

5.43

1.2

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

250

1858

1.39

5.36

3.1

2.4

1.84

1.74

0.80

229

1648

(3035715) Granulocytes [#/volume] in Blood

262

2.01

5.24

3.9

3.5

4.91

4.07

e9/l

1.07

262

(4094501) Cardiovascular stress test using bicycle ergometer

525

0.36

5.21

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

203

2.14

5.15

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

598

1.65

5.09

2.7

1.7

432.39

295.70

mu/l

1.44

547

(3024869) Neuronal Ab [Presence] in Serum

5.21

5.08

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.34

5.08

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.57

5.04

1.4

2.4

21.88

18.56

umol/l

0.48

(40768800) Prostate Pathology biopsy report

2.82

4.98

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

317

1.89

4.96

1.3

1.5

108.71

133.72

au/ml

0.57

109

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

159

2241

0.69

4.96

1.6

1.8

1.83

1.48

2.40

135

1997

(3042631) Mycobacterium sp identified in Specimen

174

2.21

4.91

1.9

3.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

490

0.36

4.81

1.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.50

4.77

1.8

1.2

—

(21494434) Karyotype in Bone marrow

2.90

4.76

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

159

2.22

4.63

2.1

1.2

3.16

3.01

ug/l

0.08

147

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

520

1.66

4.63

3.4

1.5

46.36

24.19

u/ml

0.94

496

(3051611) Lipemic interference index of Serum or Plasma

153

2.24

4.60

4.3

3.5

14.81

13.57

index

0.27

(3021960) Folate [Moles/volume] in Serum or Plasma

411

4972

0.79

4.58

1.6

1.7

19.15

20.11

nmol/l

0.73

366

4206

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

608

1.61

4.56

2.2

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

263

2025

1.34

4.52

1.5

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

446

5329

0.79

4.46

2.9

3.3

778.15

1350.71

ng/l

6.66

396

4569

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.24

4.45

1.4

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

141

982

1.47

4.36

2.9

3.2

4.20

4.56

pmol/l

3.21

131

873

(3014148) Varicella zoster virus Ab [Titer] in Serum

239

1.95

4.31

1.1

1.2

—

(3009343) pH of Capillary blood

163

1170

1.43

4.30

3.7

4.8

7.42

7.41

1.33

148

965

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

292

3659

0.77

4.28

2.7

2.8

0.74

0.71

ug/l

0.26

199

2231

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

233

1.95

4.26

1.5

2.0

—

1483.64

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

382

3124

1.27

4.20

1.6

2.0

—

(3014271) Vancomycin [Susceptibility]

2.76

4.18

2.9

2.7

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1337

0.64

4.18

1.4

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1548

16298

0.82

4.08

27.7

13.0

88.92

81.56

ml/min/173m2

38.73

1443

14931

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.02

4.00

1.1

1.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.02

4.00

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

808

0.55

4.00

1.2

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

504

1.61

3.93

14.5

4.5

1.29

1.53

mg/l

1.96

457

(3023520) Reticulocytes [#/volume] in Blood

185

1390

1.36

3.75

2.8

2.3

73.26

68.97

e9/l

0.80

135

1008

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

675

0.53

3.71

1.3

1.8

2.85

5.09

mg/l

1.38

489

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.69

3.67

1.8

4.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

619

0.51

3.65

1.3

1.6

1169.15

998.84

mu/l

0.42

511

(40761536) Microorganisms panel - Urine sediment

168

1249

1.37

3.65

4.4

3.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

7.80

3.56

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

853

0.59

3.53

1.4

1.6

0.39

0.33

mg/l

0.24

423

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

123

874

1.43

3.48

5.3

3.6

49.99

48.24

0.33

123

857

(40768797) Stomach Pathology biopsy report

180

2330

0.75

3.34

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.44

3.31

2.2

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.44

3.31

2.2

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.44

3.31

2.2

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

256

3155

0.79

3.26

1.4

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

106

743

1.45

3.24

1.6

2.0

35.11

39.40

u/l

1.51

660

(3003888) Timothy IgE Ab [Units/volume] in Serum

352

0.39

3.24

1.3

1.1

5.11

4.58

u/ml

—

207

(3026493) Urate [Moles/volume] in Serum or Plasma

385

4532

0.82

3.22

3.2

2.5

309.63

350.09

umol/l

12.76

352

3990

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

147

1947

0.74

3.19

1.8

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

218

0.32

3.19

1.3

1.6

53.64

56.27

ug/l

—

218

(3022145) Colonoscopy Study observation

129

1741

0.72

3.17

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1187

0.67

3.16

1.2

1.3

—

(3000492) Spirometry study

131

1761

0.73

3.14

1.4

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

384

4510

0.82

3.13

2.2

2.4

2.80

2.71

mg/l

0.29

331

3882

(3008401) Mugwort IgE Ab [Units/volume] in Serum

343

0.40

3.06

1.3

1.1

1.68

1.45

u/ml

—

166

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

196

1534

1.31

3.05

2.1

2.4

35.55

72.02

u/l

0.59

165

1278

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.30

2.99

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.56

2.99

1.4

1.9

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1401

14743

0.85

2.93

36.9

17.7

334.65

333.18

g/l

7.09

1395

14663

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

134

1775

0.74

2.93

1.7

2.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.72

2.92

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

142

1.98

2.90

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

2.70

2.89

1.1

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

115

2.10

2.88

3.2

3.7

13.60

23.13

mu/l

1.47

109

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.68

2.87

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.68

2.87

1.2

1.1

—

(3019225) pH of Specimen

190

1503

1.29

2.75

3.6

7.38

7.36

0.59

157

1014

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.22

2.68

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

120

2.01

2.61

2.2

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

120

2.01

2.61

2.2

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

120

2.01

2.61

2.2

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

399

0.50

2.59

1.3

1.1

5.48

2.11

u/ml

0.33

233

(3024928) Oxygen saturation in Venous blood

475

1.49

2.58

4.0

3.0

62.60

63.03

0.05

459

(3023430) Cat dander IgE Ab [Units/volume] in Serum

260

0.38

2.56

1.2

1.1

17.92

5.12

u/ml

—

126

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.47

2.54

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.28

2.51

1.4

1.6

—

1469149.88

iu/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

164

2061

0.78

2.47

3.8

5.1

31.93

32.26

0.16

123

1382

(4024509) Urine culture

789

0.65

2.46

1.6

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

870

0.67

2.44

1.1

—

1.62

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

491

1.46

2.40

1.2

—

(4146454) Self-monitoring of blood glucose

208

0.38

2.40

2.4

2.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

2.40

0.0

1.2

—

0.07

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

418

1.50

2.38

2.0

2.2

131.49

132.11

g/l

0.06

339

(3022475) Manganese [Moles/volume] in Blood

6.26

2.37

1.4

1.0

0.14

umol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.26

2.37

1.0

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.65

2.36

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

365

4197

0.84

2.33

3.9

1.02

1.39

kg/l

0.50

256

2714

(3008037) Lactate [Moles/volume] in Venous blood

413

1.49

2.31

5.3

2.8

1.52

1.59

mmol/l

0.30

396

(3038515) Glucose [Moles/volume] in Venous blood

341

1.54

2.28

5.2

2.9

7.08

7.34

mmol/l

0.35

326

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

300

0.46

2.26

1.1

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

326

0.49

2.24

1.3

1.1

4.69

1.60

u/ml

—

175

(1761482) Bacteria [#/volume] in Urine by Culture

375

1.51

2.24

3.7

4.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

257

0.43

2.22

2.2

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.34

2.22

2.2

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.34

2.22

2.2

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.34

2.22

2.2

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.34

2.22

2.2

1.2

—

(3044941) Cell count panel - Synovial fluid

337

0.50

2.21

1.6

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.42

2.20

1.2

1.0

94.71

89.67

—

(3003129) Base excess in Capillary blood by calculation

214

0.42

2.18

1.6

2.3

0.20

0.42

mmol/l

—

207

(3033705) Calcium.ionized [Moles/volume] in Venous blood

173

1.74

2.17

3.3

2.3

1.18

1.19

mmol/l

0.26

173

(3037522) Nuclear Ab [Titer] in Serum

209

2499

0.82

2.04

1.3

1.4

449.33

530.07

titre

0.28

544

(3050794) Legionella sp Ab [Presence] in Serum

4.01

2.04

1.2

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.01

2.04

1.3

1.1

—

(3037756) Immunofixation for Serum or Plasma

263

1.57

2.01

1.5

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

140

1.80

2.01

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

243

2057

1.20

1.97

1.5

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.34

1.96

2.3

2.5

—

12.15

—

(3041354) Potassium [Moles/volume] in Venous blood

179

1.69

1.95

3.3

2.3

4.09

4.08

mmol/l

0.06

179

(3035285) Chloride [Moles/volume] in Venous blood

179

1.69

1.95

3.3

2.3

104.77

105.68

mmol/l

0.47

179

(3016750) Collection duration of Urine

1.99

1.95

2.1

528.00

506.86

min

0.62

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.57

1.94

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

158

0.38

1.88

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

1.87

0.0

1.1

—

38.16

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.86

1.86

1.9

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.17

1.82

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.17

1.82

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.27

1.80

1.3

1.1

92.33

89.89

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.58

1.80

1.2

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1033

0.75

1.79

1.7

2.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

770

0.71

1.79

1.4

1.9

4.29

6.90

iu/ml

—

168

(3035320) C reactive protein [Mass/volume] in Body fluid

131

1.76

1.77

1.8

2.5

36.86

33.57

mg/l

0.14

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

652

0.68

1.77

1.7

1.6

20.18

15.30

u/ml

0.21

141

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.34

1.74

1.2

2.1

3.33

5.22

ug/l

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.23

1.74

1.3

1.1

89.83

102.37

0.76

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

329

3726

0.86

1.73

1.6

1.7

41667148.80

44190962.02

pmol/l

0.02

276

3107

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

250

1.53

1.71

1.4

1.3

0.62

7.74

nmol/l

0.50

240

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

1.70

0.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.70

0.0

1.1

—

56.31

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

161

0.43

1.67

1.4

99.20

221.18

pmol/l

—

161

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.84

1.61

1.1

1104.17

1694.85

miu/ml

1.33

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

190

0.47

1.61

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.70

1.58

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.70

1.58

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.70

1.58

1.4

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

208

1.55

1.54

1.3

0.20

0.19

nmol/l

0.06

171

(40757373) Influenza virus identified in Isolate

2.43

1.53

1.5

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

861

0.75

1.53

1.5

2.2

—

(3008898) HLA-B27 [Presence]

632

0.71

1.53

1.0

1.1

—

(3036603) Volume of Urine

1.83

1.51

1.8

1.5

1856.24

1866.62

0.02

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.86

1.50

2.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

367

0.62

1.47

1.3

1.5

82.58

61.28

ug/l

0.64

302

(3004775) Volume in Urine collected for unspecified duration

124

1.70

1.47

2.0

2.4

640.93

629.13

0.06

(3011288) Drugs identified in Urine by Screen method Nominal

510

0.68

1.47

1.9

3.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.23

1.46

1.3

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

186

2170

0.84

1.44

1.4

1.5

—

(4062490) Immunoglobulin typing, IgG

165

1.58

1.40

1.3

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

386

0.64

1.40

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

137

0.44

1.40

40.7

21.2

1142.17

1444.05

nmol/l

—

131

(3048929) Epstein Barr virus Ab [Presence] in Serum

581

1.30

1.39

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

924

0.77

1.38

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

427

1.34

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.92

1.33

1.1

—

4.38

iu/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.32

0.0

1.1

—

41.62

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

351

1.38

1.31

1.4

251.22

241.97

u/ml

0.06

203

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

150

0.46

1.31

1.0

1.3

10.21

8.95

mmol/l

—

142

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

1.55

1.29

1.3

1.4

6.06

6.89

g/l

0.56

130

(3028192) IgG subclass 2 [Mass/volume] in Serum

169

1.55

1.29

1.3

1.4

2.52

2.96

g/l

0.60

128

(3024139) IgG subclass 3 [Mass/volume] in Serum

169

1.55

1.29

1.3

1.4

0.32

0.36

g/l

0.36

130

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.89

1.28

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.89

1.28

1.3

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

132

0.45

1.28

17.7

16.7

582.67

808.16

nmol/l

—

127

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

156

1329

1.19

1.25

3.8

2.3

68.77

67.70

ml/min/173m2

0.09

538

(3050129) First trimester maternal screen panel - Serum or Plasma

409

0.68

1.23

1.1

1.5

—

(1002224) Polysomnography panel

908

0.79

1.22

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.05

1.22

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.05

1.22

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

651

6935

0.91

1.19

4.1

3.6

0.05

0.10

estimate

0.32

183

1461

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.84

1.19

1.0

5.7

71.14

67.49

mg/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

475

0.71

1.18

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

171

0.52

1.18

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

274

1.39

1.15

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.81

1.15

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

431

1.31

1.13

2.8

1.5

1.94

1.35

ratio

0.58

250

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.00

1.12

2.4

2.6

0.63

0.61

mmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

341

0.67

1.11

1.3

1.5

1.63

1.15

ratio

0.50

210

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

341

0.67

1.11

1.3

1.5

0.90

0.95

ratio

0.20

210

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

341

0.67

1.11

1.3

1.5

1.40

1.19

ratio

0.47

210

(3000330) Specific gravity of Urine by Test strip

101

838

1.22

1.10

3.8

3.3

1.02

ratio

2.28

766

(3047007) Chlamydophila sp Ab [Presence] in Serum

256

0.62

1.09

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

292

0.65

1.09

1.3

1.5

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.38

1.09

1.2

1.1

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.38

1.09

1.2

—

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

456

4920

0.91

1.09

3.4

2.9

0.08

0.02

0.33

113

(4198724) Urine methamphetamine measurement

1.73

1.09

1.1

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

547

0.74

1.08

1.3

118.00

230.86

miu/ml

1.24

246

(3007164) IgA [Mass/volume] in Serum or Plasma

317

3485

0.89

1.08

1.8

1.4

2.18

2.48

g/l

1.16

217

2139

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

339

0.67

1.08

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

164

0.55

1.08

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

164

0.55

1.08

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

164

0.55

1.08

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

220

1.42

1.05

1.3

1.2

—

nmol/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

272

1.37

1.03

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.74

1.02

2.2

2.5

—

(3026470) Cobalt [Mass/volume] in Blood

107

0.47

1.01

2.2

2.3

3.00

2.97

ug/l

—

102

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

180

1.45

1.00

1.5

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

250

0.64

1.00

1.1

—

2.06

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

158

0.57

0.98

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

570

0.77

0.97

1.9

196.53

214.90

pmol/l

0.63

543

(3004616) Nuclear Ab [Presence] in Serum

222

0.63

0.95

1.4

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

745

0.80

0.94

2.3

2.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

281

0.67

0.93

1.3

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

339

1.30

0.92

1.5

1.7

—

(36660697) Celiac disease serology panel - Serum

124

1432

0.86

0.91

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

278

0.68

0.89

1.3

1.4

1.28

0.00

193

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

108

1258

0.85

0.89

2.9

4.1

87.87

89.43

ng/l

0.06

1103

(3052592) Norovirus Ag [Presence] in Stool

2.07

0.89

1.2

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

245

1.35

0.89

1.5

1.4

70.64

73.03

pmol/l

0.05

239

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

0.58

0.88

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

128

0.55

0.88

1.1

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

499

5309

0.92

0.87

2.6

2.4

53.53

60.47

u/l

4.01

470

4897

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

169

1.42

0.87

1.6

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

168

0.59

0.86

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

1.42

0.85

1.6

1.2

—

(3022313) Gas panel - Capillary blood

100

856

1.18

0.83

4.2

5.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

171

1.41

0.83

1.6

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

1.32

0.82

1.1

1.2

4.46

6.17

u/ml

0.31

125

(3018133) Calcium [Moles/volume] in Urine

1.74

0.82

1.3

2.3

2.79

2.60

mmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

197

1.38

0.82

1.9

1.3

—

(4281824) Cell count and differential, peritoneal fluid

1.65

0.81

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.61

0.81

1.1

1.4

4.56

5.07

umol/l

0.17

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1139

0.85

0.81

1.2

205.76

132.89

u/ml

0.50

453

(3016879) Cocaine [Presence] in Urine

695

0.82

0.79

2.4

2.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.82

0.79

6.3

7.9

11.30

10.53

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

0.79

0.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

738

0.82

0.79

2.3

2.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

149

0.60

0.79

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

106

1.51

0.79

1.6

1.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

0.78

0.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

748

0.82

0.78

2.4

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.51

0.78

1.0

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

473

0.78

1.5

2.1

4.41

15.35

iu/l

0.47

204

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1203

11694

1.07

0.77

3.8

3.3

62.76

45.10

u/l

3.89

1153

10987

(3044927) Protein electrophoresis panel - Urine

186

0.64

0.76

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

485

1.22

0.76

3.0

1.5

38.86

35.43

mg/l

0.14

409

(3027008) Opiates [Presence] in Urine

746

0.83

0.76

2.3

2.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.77

0.76

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

0.62

0.75

1.0

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

487

1.22

0.74

3.0

1.5

36.92

44.07

mg/l

0.63

412

(3045414) Leukocytes [Presence] in Urine

144

1615

0.88

0.74

1.9

2.0

0.00

0.01

estimate

0.78

338

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

174

1566

1.12

0.73

2.1

2.4

4.50

8.04

ug/l

5.07

155

1392

(3004588) Protein electrophoresis panel - Serum or Plasma

124

1093

1.14

0.73

2.7

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

685

0.83

0.71

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.71

0.70

1.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

216

0.69

1.1

1.3

—

60.48

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

178

1.35

0.68

1.6

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

145

1.38

0.65

1.1

1.2

107.15

108.73

pmol/l

0.04

145

(4211845) Urine protein measurement

1.54

0.65

2.9

3.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

260

1.27

0.64

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

589

0.83

0.63

2.6

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

488

1.19

0.63

2.4

2.1

1937.29

5119.35

u/l

0.82

211

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

1.45

0.62

2.6

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.55

0.62

1.5

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.67

0.61

1.2

108.60

94.23

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

179

1634

1.10

0.61

2.8

2.3

12.23

14.69

nmol/l

3.76

161

1498

(4195642) Thrombophilia screening test

244

1.27

0.61

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.42

0.61

1.2

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

244

0.74

0.60

1.5

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.60

0.0

1.3

—

6.07

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.60

0.0

1.2

—

31.57

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.2

—

29.83

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.50

0.59

1.0

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.54

0.59

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

409

1.20

0.59

1.1

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

145

1313

1.11

0.58

3.3

1.6

65.32

67.02

g/l

1.64

130

1196

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.57

0.58

1.4

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

528

0.83

0.57

1.1

1.4

—

9.73

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

430

0.81

0.57

2.7

2.3

146.54

109.74

ug/min

0.18

271

(3015736) pH of Urine

712

7373

0.95

0.55

3.4

3.3

6.39

6.22

3.29

383

4122

(3025130) Human papilloma virus identified in Specimen

228

0.74

0.54

1.4

1.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

159

0.69

0.54

1.4

1.1

—

67.29

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

458

0.83

0.53

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.52

0.52

1.7

2.12

1.93

umol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

619

0.85

0.52

1.9

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

0.68

0.52

1.6

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.47

0.50

1.3

1.1

114.09

80.62

u/l

0.35

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

839

0.88

0.50

2.5

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

162

1.30

0.50

1.9

1.8

1.62

1.93

g/24h

0.19

(3012565) Volume of 24 hour Urine

1.49

0.49

1.9

2.1

2407.00

2085.24

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

180

1.28

0.49

1.6

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

827

0.88

0.49

1.2

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.45

0.48

1.3

1.1

30.73

21.06

u/l

0.21

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.46

0.46

5.7

7.4

6.20

5.16

kpa

—

(3047189) Immunofixation for 24 hour Urine

1.46

0.46

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

0.76

0.46

1.1

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

0.61

0.45

1.0

1.3

—

6.23

—

(3010838) Calcium [Moles/time] in 24 hour Urine

292

1.20

0.45

1.5

2.1

5.01

5.25

mmol/24h

0.13

257

(3024980) IgG subclass 4 [Mass/volume] in Serum

283

1.20

0.45

1.3

1.8

0.52

0.89

g/l

2.36

232

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

274

1.21

0.45

1.1

1.3

1.30

3.84

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

810

0.89

0.44

1.8

2.0

0.05

0.98

estimate

0.48

258

(21494890) Protein electrophoresis panel - 24 hour Urine

130

1.31

0.44

1.9

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

0.69

0.43

1.6

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

490

1.15

0.42

2.6

1.4

0.07

0.00

g/l

0.46

450

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

149

1.28

0.41

1.1

—

(3004451) EKG impression Narrative

1.36

0.41

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.52

0.41

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

729

1.12

0.41

1.9

1.7

1.70

1.51

g/l

0.84

629

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.40

0.0

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

470

4877

0.95

0.40

4.0

3.1

0.01

0.22

estimate

0.60

173

1411

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

578

1.13

0.40

1.1

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.2

—

6.23

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

330.12

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

1.32

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.7

—

0.59

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

106

1.32

0.39

1.4

1.3

41.86

20.05

umol/l

1.05

100

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

7.01

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.39

0.38

1.0

1.6

1.16

1.19

mmol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.32

0.37

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

115

0.69

0.37

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1735

17502

0.95

0.37

32.4

16.8

3.95

3.98

mmol/l

9.62

1721

17107

(3006462) Nitrate [Presence] in Urine

1.39

0.37

3.2

3.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

393

3779

1.05

0.36

1.9

1.8

2.02

1.20

mg/l

2.20

323

2879

(3002079) Sodium [Moles/time] in 24 hour Urine

1.29

0.36

1.0

1.4

178.11

170.92

mmol/24h

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.65

0.35

1.8

4.7

4.88

8.44

mg/l

—

(3017569) Oxygen content in Arterial blood

1.32

0.35

1.2

1.9

16.52

16.73

0.12

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

470

1.13

0.35

2.7

1.4

0.00

g/l

-0.00

422

(3000034) Microalbumin [Mass/volume] in Urine

144

0.76

0.33

2.5

3.2

5.93

40.50

mg/l

—

112

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

285

1.16

0.32

1.2

1.1

—

0.98

—

(44806420) Estimation of glomerular filtration rate

176

0.79

0.32

2.6

2.5

—

(4034850) Laboratory test

589

0.90

0.30

7.9

9.3

—

(3012441) Differential panel - Pleural fluid

129

1.24

0.30

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

102

1.28

0.30

1.0

1.3

129.77

142.06

nmol/l

0.37

102

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.29

0.30

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

1.15

0.30

1.5

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

535

0.89

0.29

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

227

0.84

0.28

1.1

3.42

2.39

eliau/ml

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.32

0.28

1.6

1.7

26.50

27.12

umol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1715

17022

1.04

0.28

29.1

13.9

20.74

23.55

mg/l

4.23

1612

13709

(3019832) Treponema pallidum Ab [Presence] in Serum

170

1616

1.06

0.27

1.3

1.8

—

(3017732) Neutrophils [#/volume] in Blood

217

2078

1.05

0.26

4.1

2.9

4.38

4.59

e9/l

0.19

195

1788

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.69

0.26

1.0

2.8

21.66

123.28

ug/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.69

0.26

4.6

5.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

203

0.84

0.26

1.0

—

(40768443) Skin Pathology biopsy report

644

0.91

0.25

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

277

0.86

0.25

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

476

0.90

0.24

1.3

1.4

275.12

306.46

ug/g

0.52

289

(40768441) Liver Pathology biopsy report

1.18

0.24

1.0

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

725

0.92

0.24

1.7

1.9

40.87

39.51

nmol/l

0.18

699

(3002523) Influenza virus A Ag [Presence] in Specimen

329

0.88

0.24

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.27

0.24

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.71

0.24

1.3

2.4

180.17

154.78

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

124

1.21

0.24

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

328

0.88

0.23

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

483

0.91

0.22

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.22

0.22

1.0

1.2

280.20

234.78

pmol/l

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

0.05

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

369.42

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.3

—

3.19

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.14

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.29

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1736

17457

0.97

0.20

32.8

16.7

138.92

139.75

mmol/l

26.47

1723

17101

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

584

0.92

0.20

1.7

1.6

0.00

0.19

iu/ml

—

104

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.16

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.18

0.19

1.0

1.6

363.33

65.76

nmol/24h

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

146

1.17

0.19

3.5

2.5

1.45

1.63

u/field

0.12

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.15

0.19

3.5

3.1

9.50

9.94

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.15

0.19

3.5

3.1

4.84

5.06

kpa

—

(3022621) pH of Urine by Test strip

130

1359

0.95

0.19

3.0

2.6

6.23

6.08

1.02

103

933

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.24

0.18

1.3

2.0

0.94

6.94

nmol/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

477

0.92

0.18

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.21

0.18

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

883

1.06

0.18

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

445

1.08

0.17

2.8

1.4

0.00

g/l

-0.00

421

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

148

1.15

0.17

1.1

294.71

281.44

mg/l

0.29

135

(3007566) Smooth muscle Ab [Titer] in Serum

485

1.07

0.17

1.2

1.3

50.00

101.11

titre

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.11

0.16

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.79

0.15

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

290

2969

0.97

0.15

1.7

1052.74

1171.48

nmol/l

1.81

231

2278

(4268621) Lupus anticoagulant assay

197

1.12

0.15

2.3

—

(3024263) Appearance of Synovial fluid

0.78

0.14

1.4

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

181

0.88

0.14

2.6

4.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.83

0.13

1.5

1.6

5.93

9.52

ug/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

900

9084

0.98

0.13

3.9

3.7

0.00

estimate

0.50

219

1793

(3051387) C reactive protein [Mass/volume] in Capillary blood

364

1.07

0.13

3.3

3.5

29.61

27.89

mg/l

0.07

255

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

249

1.09

0.12

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

913

9204

0.99

0.11

3.9

3.7

5.84

4.31

estimate

0.09

227

1827

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

573

1.05

0.11

2.5

1.4

1.26

0.35

g/l

1.18

495

(3028308) Erythrocytes [#/volume] in Pleural fluid

134

1.12

0.11

1.3

1.4

37401.11

80813.00

e6/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

193

1.09

0.10

1.2

1.1

—

(4015189) Microbial culture of sputum

1.11

0.09

1.4

2.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

473

0.95

0.09

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

497

1.05

0.09

1.2

1.1

—

3.75

—

(44813793) Dust mix specific IgE antibody measurement

113

0.88

0.08

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

627

1.04

0.08

2.4

1.4

2.79

2.91

g/l

0.67

558

(37208534) Antinuclear antibody arbitrary concentration in serum

0.83

0.08

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.78

0.08

1.2

1.4

7.08

9.69

mmol/l

—

(40768446) Kidney Pathology biopsy report

0.83

0.07

1.5

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

1.09

0.06

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

101

0.89

0.06

1.1

1.8

7.51

8.42

mmol/l

—

101

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

197

1.07

0.06

1.0

1.2

103.38

97.51

0.52

186

(3032773) Endomysium IgG Ab [Titer] in Serum

172

0.93

0.06

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

233

0.94

0.05

1.1

1.47

1.46

g/l

0.03

209

(3004789) Transferrin [Mass/volume] in Serum or Plasma

258

2609

0.99

0.05

2.3

2.6

2.27

2.32

g/l

0.85

243

2401

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

594

1.03

0.05

2.4

1.4

10.47

10.34

g/l

0.08

524

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

140

1421

0.98

0.05

2.1

3.3

103.05

212.38

ng/l

8.81

126

1308

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

209

2067

1.01

0.04

9.8

6.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

130

0.92

0.04

1.0

1.6

91.83

85.75

umol/l

0.20

130

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

239

2370

1.01

0.03

2.4

2.7

25.55

23.33

1.20

224

2204

(3029937) Albumin [Presence] in Urine by Test strip

499

5012

0.99

0.03

4.0

3.8

0.00

estimate

0.88

196

1663

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

1.07

0.03

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

301

1.03

0.02

1.1

1.00

118.27

iu/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

182

1.04

0.02

1.9

2.4

22.00

19.96

mg/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

670

0.98

0.02

2.3

1.4

4.24

g/l

0.02

601

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

670

0.98

0.02

2.3

1.4

7.36

7.43

g/l

0.13

601

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

670

0.98

0.02

2.3

1.4

3.59

3.72

g/l

0.41

601

(3009261) Glucose [Presence] in Urine by Test strip

922

9237

1.00

0.02

3.9

3.7

0.01

0.02

estimate

0.11

214

1696

(3022948) Iron [Moles/volume] in Serum or Plasma

280

2812

1.00

0.01

2.3

2.6

14.20

13.41

umol/l

0.94

263

2607

(3049717) Cytology report of Urine Cyto stain

482

1.02

0.01

3.3

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

273

1.03

0.01

1.9

2.3

—

9.67

—

(3045788) Cell count panel - Pleural fluid

134

1.05

0.00

1.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

319

1.00

0.00

3.4

3.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

156

1.03

0.00

1.3

1.4

870.60

1987.91

e6/l

—

107

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1432

14323

1.00

0.00

36.9

16.7

13.88

13.50

21.62

1424

14105

(3023419) Bacteria identified in Sputum by Culture

227

1.01

0.00

1.9

2.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.93

0.00

1.1

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

0.00

1.0

1.2

38.92

39.88

g/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.4

—

410.60

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.36

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.90

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.37

—

(3017704) Immunofixation for Urine

0.96

-0.00

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.00

-0.00

2.2

1.5

0.44

0.48

e9/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

-0.00

0.0

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.00

-0.00

1.2

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

30.80

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

3.00

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.93

-0.00

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.95

-0.00

1.3

1.2

7.38

8.93

mm/h

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.77

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

839.75

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BRAIN_WIDE – Malignant neoplasm of brain, including Hilmo

GWS hits: 5

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of brain, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of brain, including Hilmo (C3_BRAIN_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints